Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 2008; Volume 73,Issue 3

Perspectives

  • You have access
    Progesterone Acts via Progesterone Receptors A and B to Regulate Breast Cancer Resistance Protein Expression
    Mary Vore and Markos Leggas
    Molecular Pharmacology March 2008, 73 (3) 613-615; DOI: https://doi.org/10.1124/mol.107.044289
  • You have access
    Distinctions between Dopamine Transporter Antagonists Could be Just around the Bend
    L. Keith Henry and Randy D. Blakely
    Molecular Pharmacology March 2008, 73 (3) 616-618; DOI: https://doi.org/10.1124/mol.107.044586

Articles

  • You have access
    Ginsenoside Rg3 Inhibits Human Kv1.4 Channel Currents by Interacting with the Lys531 Residue
    Jun-Ho Lee, Byung-Hwan Lee, Sun-Hye Choi, In-Soo Yoon, Mi Kyung Pyo, Tae-Joon Shin, Woo-Sung Choi, Yoongho Lim, Hyewhon Rhim, Kwang Hee Won, Yong Whan Lim, Han Choe, Dong-Hyun Kim, Yang In Kim and Seung-Yeol Nah
    Molecular Pharmacology March 2008, 73 (3) 619-626; DOI: https://doi.org/10.1124/mol.107.040360
  • You have access
    Antitumor Mechanisms of Systemically Administered Epidermal Growth Factor Receptor Antisense Oligonucleotides in Combination with Docetaxel in Squamous Cell Carcinoma of the Head and Neck
    Sufi Mary Thomas, Michelene Jeter Ogagan, Maria L. Freilino, Sandy Strychor, Dustin R. Walsh, William E. Gooding, Jennifer Rubin Grandis and William C. Zamboni
    Molecular Pharmacology March 2008, 73 (3) 627-638; DOI: https://doi.org/10.1124/mol.107.041160
  • You have access
    2-[2-(3,4-Dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic Acid (PD-307243) Causes Instantaneous Current through Human Ether-a-go-go-Related Gene Potassium Channels
    Earl Gordon, Irina M. Lozinskaya, Zuojun Lin, Simon F. Semus, Frank E. Blaney, Robert N. Willette and Xiaoping Xu
    Molecular Pharmacology March 2008, 73 (3) 639-651; DOI: https://doi.org/10.1124/mol.107.041152
  • You have access
    Activation of the Dual-Leucine-Zipper-Bearing Kinase and Induction of β-Cell Apoptosis by the Immunosuppressive Drug Cyclosporin A
    Silke Plaumann, Roland Blume, Svenja Börchers, Hans Jürgen Steinfelder, Willhart Knepel and Elke Oetjen
    Molecular Pharmacology March 2008, 73 (3) 652-659; DOI: https://doi.org/10.1124/mol.107.040782
  • You have access
    Identification and Characterization of Two Amino Acids Critical for the Substrate Inhibition of Human Dehydroepiandrosterone Sulfotransferase (SULT2A1)
    Lu-Yi Lu, Yin-Cheng Hsieh, Ming-Yih Liu, Yih-Hung Lin, Chun-Jung Chen and Yuh-Shyong Yang
    Molecular Pharmacology March 2008, 73 (3) 660-668; DOI: https://doi.org/10.1124/mol.107.041038
  • You have access
    Potent Inhibition of Human Apurinic/Apyrimidinic Endonuclease 1 by Arylstibonic Acids
    Lauren A. Seiple, John H. Cardellina, Rhone Akee and James T. Stivers
    Molecular Pharmacology March 2008, 73 (3) 669-677; DOI: https://doi.org/10.1124/mol.107.042622
  • You have access
    Caveolin Regulates Kv1.5 Trafficking to Cholesterol-Rich Membrane Microdomains
    Dyke P. McEwen, Qiuju Li, Sajida Jackson, Paul M. Jenkins and Jeffrey R. Martens
    Molecular Pharmacology March 2008, 73 (3) 678-685; DOI: https://doi.org/10.1124/mol.107.042093
  • You have access
    A Three-Dimensional Quantitative Structure-Activity Analysis of a New Class of Bisphenol Topoisomerase IIα Inhibitors
    Hong Liang, Xing Wu, Jack C. Yalowich and Brian B. Hasinoff
    Molecular Pharmacology March 2008, 73 (3) 686-696; DOI: https://doi.org/10.1124/mol.107.041624
  • You have access
    Derlin-1 and p97/Valosin-Containing Protein Mediate the Endoplasmic Reticulum-Associated Degradation of Human V2 Vasopressin Receptors
    Isabel Schwieger, Katja Lautz, Eberhard Krause, Walter Rosenthal, Burkhard Wiesner and Ricardo Hermosilla
    Molecular Pharmacology March 2008, 73 (3) 697-708; DOI: https://doi.org/10.1124/mol.107.040931
  • You have access
    Antitumorigenic Effects of Peroxisome Proliferator-Activated Receptor-γ in Non-Small-Cell Lung Cancer Cells Are Mediated by Suppression of Cyclooxygenase-2 via Inhibition of Nuclear Factor-κB
    Yvette Bren-Mattison, Amy M. Meyer, Vicki Van Putten, Howard Li, Katherine Kuhn, Robert Stearman, Mary Weiser-Evans, Robert A. Winn, Lynn E. Heasley and Raphael A. Nemenoff
    Molecular Pharmacology March 2008, 73 (3) 709-717; DOI: https://doi.org/10.1124/mol.107.042002
  • You have access
    Cell-Based and Biochemical Structure-Activity Analyses of Analogs of the Microtubule Stabilizer Dictyostatin
    Brianne S. Raccor, Andreas Vogt, Rachel P. Sikorski, Charitha Madiraju, Raghavan Balachandran, Kia Montgomery, Youseung Shin, Yoshikazu Fukui, Won-Hyuk Jung, Dennis P. Curran and Billy W. Day
    Molecular Pharmacology March 2008, 73 (3) 718-726; DOI: https://doi.org/10.1124/mol.107.042598
  • You have access
    The Two Isoforms of the Na+/Ca2+ Exchanger, NCX1 and NCX3, Constitute Novel Additional Targets for the Prosurvival Action of Akt/Protein Kinase B Pathway
    Luigi Formisano, Mariangela Saggese, Agnese Secondo, Rossana Sirabella, Pasquale Vito, Valeria Valsecchi, Pasquale Molinaro, Gianfranco Di Renzo and Lucio Annunziato
    Molecular Pharmacology March 2008, 73 (3) 727-737; DOI: https://doi.org/10.1124/mol.107.042549
  • You have access
    Inhibition of Inducible Nitric-Oxide Synthase Protects Human T Cells from Hypoxia-Induced Apoptosis
    Juliann G. Kiang, Sandeep Krishnan, Xinyue Lu and Yansong Li
    Molecular Pharmacology March 2008, 73 (3) 738-747; DOI: https://doi.org/10.1124/mol.107.041079
  • You have access
    Inverse Agonist and Neutral Antagonist Actions of Antidepressants at Recombinant and Native 5-Hydroxytryptamine2C Receptors: Differential Modulation of Cell Surface Expression and Signal Transduction
    Benjamin Chanrion, Clotilde Mannoury la Cour, Sophie Gavarini, Mathieu Seimandi, Laurent Vincent, Jean-François Pujol, Joël Bockaert, Philippe Marin and Mark J. Millan
    Molecular Pharmacology March 2008, 73 (3) 748-757; DOI: https://doi.org/10.1124/mol.107.041574
  • You have access
    Small-Molecule Screen Identifies Inhibitors of a Human Intestinal Calcium-Activated Chloride Channel
    Ricardo De La Fuente, Wan Namkung, Aaron Mills and A. S. Verkman
    Molecular Pharmacology March 2008, 73 (3) 758-768; DOI: https://doi.org/10.1124/mol.107.043208
  • You have access
    Dioxin-Mediated Up-Regulation of Aryl Hydrocarbon Receptor Target Genes Is Dependent on the Calcium/Calmodulin/CaMKIα Pathway
    Patricia Monteiro, David Gilot, Eric Le Ferrec, Claudine Rauch, Dominique Lagadic-Gossmann and Olivier Fardel
    Molecular Pharmacology March 2008, 73 (3) 769-777; DOI: https://doi.org/10.1124/mol.107.043125
  • You have access
    Interferon β Augments Tuberous Sclerosis Complex 2 (TSC2)-Dependent Inhibition of TSC2-Null ELT3 and Human Lymphangioleiomyomatosis-Derived Cell Proliferation
    Elena A. Goncharova, Dmitry A. Goncharov, Amelia Chisolm, Matthew S. Spaits, Poay N. Lim, Gregory Cesarone, Irene Khavin, Omar Tliba, Yassine Amrani, Reynold A. Panettieri and Vera P. Krymskaya
    Molecular Pharmacology March 2008, 73 (3) 778-788; DOI: https://doi.org/10.1124/mol.107.040824
  • You have access
    Molecular Interactions of CCR5 with Major Classes of Small-Molecule Anti-HIV CCR5 Antagonists
    Rama Kondru, Jun Zhang, Changhua Ji, Tara Mirzadegan, David Rotstein, Surya Sankuratri and Marianna Dioszegi
    Molecular Pharmacology March 2008, 73 (3) 789-800; DOI: https://doi.org/10.1124/mol.107.042101
  • You have access
    Activity and Subcellular Trafficking of the Sodium-Coupled Choline Transporter CHT Is Regulated Acutely by Peroxynitrite
    Metta Pinthong, Stefanie A. G. Black, Fabiola M. Ribeiro, Chumpol Pholpramool, Stephen S. G. Ferguson and R. Jane Rylett
    Molecular Pharmacology March 2008, 73 (3) 801-812; DOI: https://doi.org/10.1124/mol.107.040881
  • You have access
    Relationship between Conformational Changes in the Dopamine Transporter and Cocaine-Like Subjective Effects of Uptake Inhibitors
    Claus J. Loland, Rajeev I. Desai, Mu-Fa Zou, Jianjing Cao, Peter Grundt, Klaus Gerstbrein, Harald H. Sitte, Amy Hauck Newman, Jonathan L. Katz and Ulrik Gether
    Molecular Pharmacology March 2008, 73 (3) 813-823; DOI: https://doi.org/10.1124/mol.107.039800
  • You have access
    The Telomeric Protein TRF2 Is Critical for the Protection of A549 Cells from Both Telomere Erosion and DNA Double-Strand Breaks Driven by Salvicine
    Yong-Wei Zhang, Zhi-Xiang Zhang, Ze-Hong Miao and Jian Ding
    Molecular Pharmacology March 2008, 73 (3) 824-832; DOI: https://doi.org/10.1124/mol.107.039081
  • You have access
    Iron Chelation by Clinically Relevant Anthracyclines: Alteration in Expression of Iron-Regulated Genes and Atypical Changes in Intracellular Iron Distribution and Trafficking
    X. Xu, R. Sutak and D. R. Richardson
    Molecular Pharmacology March 2008, 73 (3) 833-844; DOI: https://doi.org/10.1124/mol.107.041335
  • You have access
    Progesterone Receptor (PR) Isoforms PRA and PRB Differentially Regulate Expression of the Breast Cancer Resistance Protein in Human Placental Choriocarcinoma BeWo Cells
    Honggang Wang, Eun-Woo Lee, Lin Zhou, Peter C. K. Leung, Douglas D. Ross, Jashvant D. Unadkat and Qingcheng Mao
    Molecular Pharmacology March 2008, 73 (3) 845-854; DOI: https://doi.org/10.1124/mol.107.041087
  • You have access
    An Intracellular Allosteric Site for a Specific Class of Antagonists of the CC Chemokine G Protein-Coupled Receptors CCR4 and CCR5
    Glen Andrews, Carolyn Jones and Keith A. Wreggett
    Molecular Pharmacology March 2008, 73 (3) 855-867; DOI: https://doi.org/10.1124/mol.107.039321
  • You have access
    Plasticity of Adenylyl Cyclase-Related Signaling Sequelae after Long-Term Morphine Treatment
    Michael Shy, Sumita Chakrabarti and Alan R. Gintzler
    Molecular Pharmacology March 2008, 73 (3) 868-879; DOI: https://doi.org/10.1124/mol.107.042184
  • You have access
    Lipid Composition Alters Drug Action at the Nicotinic Acetylcholine Receptor
    John E. Baenziger, Stephen E. Ryan, Michael M. Goodreid, Ngoc Q. Vuong, Raymond M. Sturgeon and Corrie J. B. daCosta
    Molecular Pharmacology March 2008, 73 (3) 880-890; DOI: https://doi.org/10.1124/mol.107.039008
  • You have access
    Identification of Oxysterol 7α-Hydroxylase (Cyp7b1) as a Novel Retinoid-Related Orphan Receptor α (RORα) (NR1F1) Target Gene and a Functional Cross-Talk between RORα and Liver X Receptor (NR1H3)
    Taira Wada, Hong Soon Kang, Martin Angers, Haibiao Gong, Shikha Bhatia, Shaheen Khadem, Songrong Ren, Ewa Ellis, Stephen C. Strom, Anton M. Jetten and Wen Xie
    Molecular Pharmacology March 2008, 73 (3) 891-899; DOI: https://doi.org/10.1124/mol.107.040741
  • You have access
    Identification of the First Synthetic Steroidogenic Factor 1 Inverse Agonists: Pharmacological Modulation of Steroidogenic Enzymes
    Andria L. Del Tredici, Carsten B. Andersen, Erika A. Currier, Steven R. Ohrmund, Luke C. Fairbain, Birgitte W. Lund, Norman Nash, Roger Olsson and Fabrice Piu
    Molecular Pharmacology March 2008, 73 (3) 900-908; DOI: https://doi.org/10.1124/mol.107.040089
  • You have access
    N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) Acts through a Novel Site as a Positive Allosteric Modulator of Group 1 Metabotropic Glutamate Receptors
    Yelin Chen, Cyril Goudet, Jean-Philippe Pin and P. Jeffrey Conn
    Molecular Pharmacology March 2008, 73 (3) 909-918; DOI: https://doi.org/10.1124/mol.107.040097
  • You have access
    A Novel High-Throughput Screening System Identifies a Small Molecule Repressive for Matrix Metalloproteinase-9 Expression
    Rajesh R. Nair, Hector Avila, Xujun Ma, Zhengxin Wang, Michelle Lennartz, Bryant G. Darnay, Douglas D. Boyd and Chunhong Yan
    Molecular Pharmacology March 2008, 73 (3) 919-929; DOI: https://doi.org/10.1124/mol.107.042606
  • You have access
    Insulin-Like Growth Factor Type-I Receptor-Dependent Phosphorylation of Extracellular Signal-Regulated Kinase 1/2 but not Akt (Protein Kinase B) Can Be Induced by Picropodophyllin
    Radu Vasilcanu, Daiana Vasilcanu, Bita Sehat, Shucheng Yin, Ada Girnita, Magnus Axelson and Leonard Girnita
    Molecular Pharmacology March 2008, 73 (3) 930-939; DOI: https://doi.org/10.1124/mol.107.040014
  • You have access
    State- and Use-Dependent Block of Muscle Nav1.4 and Neuronal Nav1.7 Voltage-Gated Na+ Channel Isoforms by Ranolazine
    Ging Kuo Wang, Joanna Calderon and Sho-Ya Wang
    Molecular Pharmacology March 2008, 73 (3) 940-948; DOI: https://doi.org/10.1124/mol.107.041541
  • You have access
    The Breast Cancer Resistance Protein (Bcrp1/Abcg2) Limits Fetal Distribution of Glyburide in the Pregnant Mouse: An Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study
    Lin Zhou, Suresh Babu Naraharisetti, Honggang Wang, Jashvant D. Unadkat, Mary F. Hebert and Qingcheng Mao
    Molecular Pharmacology March 2008, 73 (3) 949-959; DOI: https://doi.org/10.1124/mol.107.041616
  • You have access
    Atomic Force Microscopy Reveals the Stoichiometry and Subunit Arrangement of the α4β3δ GABAA Receptor
    Nelson P. Barrera, Jill Betts, Haitao You, Robert M. Henderson, Ian L. Martin, Susan M. J. Dunn and J. Michael Edwardson
    Molecular Pharmacology March 2008, 73 (3) 960-967; DOI: https://doi.org/10.1124/mol.107.042481
  • You have access
    Modulation of Receptor Phosphorylation Contributes to Activation of Peroxisome Proliferator Activated Receptor α by Dehydroepiandrosterone and Other Peroxisome Proliferators
    Viola Tamasi, Kristy K. Michael Miller, Sharon L. Ripp, Ermin Vila, Thomas E. Geoghagen and Russell A. Prough
    Molecular Pharmacology March 2008, 73 (3) 968-976; DOI: https://doi.org/10.1124/mol.107.036780
  • You have access
    N-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): A Novel, Selective KCNQ2/Q3 Potassium Channel Activator
    A. D. Wickenden, J. L. Krajewski, B. London, P. K. Wagoner, W. A. Wilson, S. Clark, R. Roeloffs, G. McNaughton-Smith and G. C. Rigdon
    Molecular Pharmacology March 2008, 73 (3) 977-986; DOI: https://doi.org/10.1124/mol.107.043216
  • You have access
    A New Mechanism of 6-((2-(Dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one Dihydrochloride (TAS-103) Action Discovered by Target Screening with Drug-Immobilized Affinity Beads
    Makoto Yoshida, Yasuaki Kabe, Tadashi Wada, Akira Asai and Hiroshi Handa
    Molecular Pharmacology March 2008, 73 (3) 987-994; DOI: https://doi.org/10.1124/mol.107.043307
  • You have access
    Direct Role of Streptozotocin in Inducing Thermal Hyperalgesia by Enhanced Expression of Transient Receptor Potential Vanilloid 1 in Sensory Neurons
    Reddy M. Pabbidi, De-Shou Cao, Arti Parihar, Mary E. Pauza and Louis S. Premkumar
    Molecular Pharmacology March 2008, 73 (3) 995-1004; DOI: https://doi.org/10.1124/mol.107.041707
  • You have access
    Combined Effects of Sulindac and Suberoylanilide Hydroxamic Acid on Apoptosis Induction in Human Lung Cancer Cells
    Sung-Keum Seo, Hyeon-Ok Jin, Hyung-Chahn Lee, Sang-Hyeok Woo, Eun-Sung Kim, Doo-Hyun Yoo, Su-Jae Lee, Sungkwan An, Chang-Hun Rhee, Seok-Il Hong, Tae-Boo Choe and In-Chul Park
    Molecular Pharmacology March 2008, 73 (3) 1005-1012; DOI: https://doi.org/10.1124/mol.107.041293
  • You have access
    Analysis of Promoter Regions Regulating Basal and Interleukin-4-Inducible Expression of the Human CB1 Receptor Gene in T Lymphocytes
    Christine Börner, Andrea Bedini, Volker Höllt and Jürgen Kraus
    Molecular Pharmacology March 2008, 73 (3) 1013-1019; DOI: https://doi.org/10.1124/mol.107.042945
  • You have access
    Inhibition of Sodium Channel Gating by Trapping the Domain II Voltage Sensor with Protoxin II
    Stanislav Sokolov, Richard L. Kraus, Todd Scheuer and William A. Catterall
    Molecular Pharmacology March 2008, 73 (3) 1020-1028; DOI: https://doi.org/10.1124/mol.107.041046
  • You have access
    Midazolam Metabolism in Cytochrome P450 3A Knockout Mice Can Be Attributed to Up-Regulated CYP2C Enzymes
    Robert A. B. van Waterschoot, Antonius E. van Herwaarden, Jurjen S. Lagas, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Joyce A. Goldstein, Darryl C. Zeldin, Jos H. Beijnen and Alfred H. Schinkel
    Molecular Pharmacology March 2008, 73 (3) 1029-1036; DOI: https://doi.org/10.1124/mol.107.043869
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 73 (3)
Molecular Pharmacology
Vol. 73, Issue 3
1 Mar 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Perspectives
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics